Citadel Securities Starts The Medicines Company (MDCO) at Add; Positive Resolution for Angiomax Patent Battle Expected
Tweet Send to a Friend
Citadel Securities initiates coverage on The Medicines Company (NASDAQ: MDCO) with a Add. PT $20.00.
Citadel analyst says, "We expect ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citadel analyst says, "We expect ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE